Search results with tag "Depo provera"
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzVersion: pfddepoi11017 Supersedes: pfddepoi11016 Page 1 of 18 NEW ZEALAND DATA SHEET. 1. PRODUCT NAME . DEPO-PROVERA® 150 mg/mL Injection (depot) . 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Consumer Medicine Information Template - Medsafe
www.medsafe.govt.nzDEPO-PROVERA® 3 after the baby was born, after your doctor has checked that you are not pregnant. If you are switching from another form of contraception, then DEPO-
USPI medroxyprogesterone acetate - Depo …
www.pfizer.com3 If the patient is exposed to DEPO-PROVERA Sterile Aqueous Suspension during the first four months of pregnancy or if she becomes pregnant while taking this drug, she
How to Code for Depo Provera Services - Maryland
health.maryland.govdrug); subcutaneous or intramuscular). • However, per CPT, it is not appropriate to report injection administration code . 96372. without direct physician or other qualified health care professional supervision, unless administered in a hospital setting. In that case, report instead, code . 99211 (Office or other outpatient visit for the
Depo-Provera for Contraception - University of California ...
uhs.berkeley.eduDepo Provera (Depo medroxyprogesterone Acetate or DMPA) is a long acting progestin given by intramuscular ... In 2004, the U.S. Food and Drug Administration issued a “Black Box Warning” that “ women who use Depo-Provera may lose significant bone mineral density (BMD) which is greater with increasing duration of use and may ...
DEPO PROVERA (3-Month Shot) - Cedar River Clinics
www.fwhc.org1165.00 Forms/Depo Provera.JS: 6/11 Drug Interactions Few medications lower the effectiveness of Depo-Provera. Women with Cushing’s syndrome may take medications
Depo-Provera General Information - Dr. Sweet
www.dreamababy.comDepo-Provera General Information (cont.) Page 2 of 2 Administration:! Depo-Provera is usually injected at a dosage of 150 mg every three months and is usually given within the
DEPO-PROVERA- medroxyprogesterone acetate injection ...
rsc.niaid.nih.govDepo-Provera CI can pose an additional risk in patients with risk factors for osteoporosis (e.g., metabolic bone disease, chronic alcohol and/or tobacco use, anorexia nervosa, strong family history of osteoporosis or chronic use of drugs that can reduce bone mass such as anticonvulsants or corticosteroids).